Imprinted genes play an important role in placental and embryonic development. Abnormalities in their regulation can result in placental and embryonic dysplasia, leading to congenital diseases. The imprinting state, expression, and function of aquaporin-1 (Aqp1) were explored in knockout mice by imprinting analysis, real-time PCR, and immunohistochemistry. In the present study, Aqp1 was identified as a new, imprinted, and placenta-specific maternally expressed gene in the mouse. Compared with wild-type Aqp1 +/+ mice, there was significant placental and embryonic overgrowth in Aqp1 À/+ (loss of maternal allele) and Aqp1 À/À mice, but not in Aqp1 +/À (loss of paternal allele) mice at Embryonic Day (E) 12.5-E18.5. In addition, the masses of Postnatal Day 0 (P0) embryos (Aqp1 À/À and Aqp1 À/+ ) were highest among the four types. In Aqp1 À/+ and Aqp1 À/À mice, phenotypic analysis indicated that the number and branching of blood vessels, as well as the labyrinth area, increased significantly in placentae of E12.5-E18.5 mice. Moreover, there were abnormalities in the placental junctional zone and the labyrinthine zone at E15.5. Quantitative analysis showed that Aqp1 expression decreased significantly in the placentae of Aqp1 À/+ and Aqp1 À/À mice at E15.5, and that the AQP1 protein expression signals were detected weakly in the decidual and spongioblast layers. Our results demonstrate that Aqp1 is maternally expressed in the placenta, and that its deficiency resulted in placental abnormalities in the mouse. Aqp1 may have a specific inhibitory role in mouse placental development. These results provide new insights for the treatment of diseases relating to placental and embryonic development.
INTRODUCTION
Imprinted genes are expressed by only one of the parental chromosomes and are important for placental development and fetal growth [1, 2] . Over 100 imprinted genes have been identified in mice [3] . Several imprinted genes are maternally expressed, such as H19 [4] and Igf2r [5] , while others are paternally expressed, such as Igf2 [6] and Peg3 [7] . For some genes, imprinted expression is placenta specific; examples include Phlda2/Ipl [8] , Qpct [9] , Pde10a, Phf17, Zfp64, Htra3, and Phactr2 [10] , Airn, Ascl2, and Tssc4, among others [11] . These genes play an indispensable role in placental development and fetal growth [12] . Moore and Haig proposed a conflict theory in which paternally and maternally expressed genes play opposite roles in the allocation of maternal nutrients to the embryo [13] . This theory assumes that paternally expressed genes facilitate the provision of maternal nutrients to paternal offspring; maternally expressed genes, by contrast, restrict excessive resources to individual offspring to facilitate a balanced allocation of maternal nutrients [14] . For example, Rtl1 is a paternally expressed gene, and placental and embryo weights decrease in the Rtl1 knockout mouse [15] . However, knockout of the maternally expressed H19 gene results in placental and fetal overgrowth, as well as an increase in the trophoblast area of the placenta [4] .
Phlda2 (also known as Tssc3 or Ipl) is a maternally expressed gene that encodes a small cytoplasmic protein containing a pleckstrin-homology domain [8] . Phlda2 knockout led to a reduction of the spongiotrophoblast endocrine compartment and an enlarged placenta. In addition, PHLDA2 can limit the accumulation of placental glycogen and placental growth by regulating the signaling function of the placenta [16] . In mammals, the placental nutrients support fetal growth [14, 17, 18] , which allows the labyrinthine layer to transfer the maternal nutrients to the fetus [4] . Furthermore, the effects of imprinted genes on fetal growth may be partly regulated by the changes in the labyrinthine trophoblast during placental development [14] . It was also postulated that the spongiotrophoblast layer may produce specific signals to facilitate formation of the labyrinthine layer [19] .
By high-throughput bioinformatics analysis and a study of the common features of imprinted genes, candidate imprinted genes were screened and single-nucleotide polymorphisms (SNPs) were identified successfully. Aquaporin-1 (Aqp1) was identified as a new imprinted gene. Aqp1, which resides in the interior of the Mest-Nap1l5 imprinted region, is located on mouse chromosome 6. AQP1 is a 13-kb plasma membrane water-transporting protein that contains four exons [20] . It is expressed by the lung [21] , kidney [22] , ileum [23] , microvascular and cardiac endothelia cells [24] , as well as by several carcinomas [25] . Currently, four paternally expressed genes (Mest, Copg2as2, Copg2as2, Nap1l5) and two maternally expressed genes (Copg2, Klf14) have been identified in the Mest-Nap1l5 imprinted region. Knockdown of Aqp1 inhibits the proliferation and migration of lung cancer [26] and osteosarcoma [27] cells, and myocardial infarction was reduced in Aqp1 À/À knockout mice [28] . In addition, acute lung injury was alleviated by overexpression of Aqp1 [29] .
Previous research mainly focused on the significant roles of Aqp1 in water transportation and cancer treatment. However, the imprinting status of Aqp1 and its effects on the development of mouse embryonic tissues have not been reported until now. Information on the imprinting status of Aqp1 may also close the gaps in knowledge between placental and embryo development. This prompted us to explore the imprinting statuses of Aqp1 in mouse key tissues and what the function of Aqp1 is for the development of placentae and embryos during pregnancy. Therefore, we performed the imprinting analysis of Aqp1 in mouse tissues and studied the effect on the placental and embryo development of Aqp1 deletion. Aqp1 is expected to regulate the newborn embryonic masses effectively and the placental efficiency for nutrient transport, which improves the quality of fetal birth. The imprinting of Aqp1 also offers a theoretical basis for the treatment of congenital developmental diseases. 
MATERIALS AND METHODS

Animals and Preparation of Embryos
Imprinting Analysis
The SNP was used to discriminate the DNA polymorphisms. For Aqp1, a C/T SNP was found in Aqp1 after mating C57BL/6 with DBA mice. First, genomic DNA was extracted from C57BL/6 (B6) and DBA/2 and BDF1 (C57BL/6/3DBA/2?) mouse tissues and digested with proteinase K (Roche, Mannheim, Germany), followed by phenol chloroform extraction and ethanol precipitation. Total RNA was isolated from DBF1 (DBA/2/ 3C57BL/6?) and BDF1 (C57BL/6/3DBA/2?) mouse tissues using RNAiso Plus (TaKaRa, Dalian, China) according to the manufacturer's instructions. Complementary DNA was synthesized using the PrimeScript RT reagent kit with gDNA Eraser (TaKaRa). The primers used for RT-PCR were as follows: 5 0 -ACT CAC TCT AAG ACC TTG-3 0 (sense) and 5 0 -AAA ATG ACC TTC GTT CTG-3 0 (antisense). The amplified products were purified and directly sequenced.
Histology and Morphometric Analysis
Placentae and embryos from E12.5, E15.5, and E18.5 conceptuses were dissected free of fetal membranes and weighed. The E12.5 and E18.5 placentae were positioned with the labyrinthine zone facing upward, and the blood vessels of the labyrinthine zone were visualized under an SZX7 stereomicroscope (Olympus, Tokyo, Japan). The E15.5 placentae were bisected midsagittally, and one half was fixed in 4% paraformaldehyde and embedded in paraffin, sectioned, stained with hematoxylin and eosin (H&E), and the gross placental morphology analyzed. The entire placental images were saved as TIFF files and then analyzed in Image-Pro Plus version 6.0 software (Media Cybernetics, Bethesda, MD). Specifically, the pixel size was established using the scale bar of the image and ''spatial calibration'' tool of the software, which was necessary in pixel based measurement. The segmentation and count/size tools were used to determine the area of each placental layer and the number of blood vessels in the labyrinthine layer.
For immunohistochemistry, the paraffin blocks were sectioned at a thickness of 5 lm, and the placental cross-sections were deparaffinized. The antigens were retrieved by boiling cross-sections in 10 mM sodium citrate buffer (pH 6.0) for 10 min. The cross-sections were incubated with an anti-AQP1 (1:400; Sigma, Munich, Germany) or an anti-CD31 (1:50; Abcam, Cambridge, U.K.) antibody for vessel endothelial cells overnight at 48C. The sections were then washed three times with PBS, and incubated with an Alexa Flour 488-labeled secondary antibody (1:1000; Invitrogen, Carlsbad, CA) for 1 h at 378C, washed three times, and counterstained with 4 0 ,6-diamidino-2-phenylindole (Invitrogen) for 10 min at room temperature. The antibodies were diluted with 5% bovine serum albumin in PBS. Normal IgG served as the negative control. The signals were imaged at the same exposure time by using an Olympus IX71 fluorescence microscope (Olympus).
Real-Time Quantitative RT-PCR
First, the different tissues (brain, tongue, heart, lung, liver, kidney, and placenta) were harvested from Aqp1
, and Aqp1 À/À mice at E15.5. RNA was isolated and cDNA was synthesized as previously described. Real-time quantitative RT-PCR (qRT-PCR) was performed with the SYBR Premix Ex Taq kit (TaKaRa) and the Applied Biosystems 7500 Real-Time PCR system (Applied Biosystems, Foster City, CA); b-actin served as the reference gene, and Aqp1 expression was determined with the relative standard curve method. The Aqp1 primers were as follows: 5 0 -ACA TCA TCG CCC AGT GTG T-3 0 (sense) and 5 0 -CTG CAG AGT GCC AAT GAT CTC-3 0 (antisense). The b-actin primers were as follows: 5 0 -AAA TGG TGA AGG TCG GTG TGA-3 0 (sense) and 5 0 -CCG TTG AAT TTG CCG TGA GTG-3 0 (antisense).
DNA Methylation Analysis
DNA was isolated from the brain, tongue, and liver of wild-type Aqp1 þ/þ mice, and the bisulfite modification was performed as previously described [30] . Bisulfite-treated DNA samples were amplified by nested PCR using the 23 GoldStar Best Master Mix (Cowin Biotech, Beijing, China) and Applied Biosystems 3200 (Applied Biosystems). For the Aqp1 promoter, the nested PCR primers were as follows: 5 0 -TAA TTT TGT TTA GAG TGG GAT GG-3 0 (forward), 5 0 -AAC CTC TCC TTA CTC CTA ACC C-3 0 (reverse-in), 5 0 -AAC TCC CTC CAA AAA CTA AAC C-3 0 (reverse-out). For the Aqp1 exon 1, the nested PCR primers were as follows: 5 0 -GTG GTT GAG TTT TTG GTT ATG A-3 0 (forward), 5 0 -CAA ATA AAA CCA ACT CCC TCT C-3 0 (reverse-in), 5 0 -ATT TTG GTT TAA AGT GTG GGT T-3 0 (reverse-out). The PCR products were subcloned into the pMD19T-vector (TaKaRa), and the plasmid DNA was sequenced. Qpct methylation data served as the negative control, and are provided in appendix (Supplemental Fig. S2 ).
Statistical Analysis
Data are presented as the means 6 SD of at least four independent experiments. ANOVA was used to analyze the significance of difference, GUO ET AL. 
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Aqp1 followed by the Dunnett post hoc test. P values less than 0.05 were considered statistically significant.
RESULTS
Aqp1
Is Maternally Expressed in Mouse Placentae at E15.5
Aqp1 localized to mouse chromosome 6 (chr6: 55336299-55348555) and contained four exons (Fig. 1A) , encoding a 29-kDa protein. To analyze the allele-specific expression of Aqp1, a C/T SNP in exon 4 was used to discriminate the two parental alleles in C57BL/6 (B6) and DBA mice. PCR products amplified from tissues of the mouse lines, BDF1 and DBF1, were directly sequenced. As indicated from sequencing chromatograms, Aqp1 was identified as a new, specifically maternally expressed gene in the placenta at E15.5 (Fig. 1B) .
Histological Analysis of Placentae
To analyze the effects of maternally expressed Aqp1 on the placenta, we obtained Aqp1 knockout Aqp1 À/À mice, maternal-Aqp1 knockout Aqp1 À/þ mice, paternal-Aqp1 knockout Aqp1 þ/À mice, and wild-type Aqp1 þ/þ mice, and then performed morphological analyses. Embryonic and placental masses were highest at each time point up to Postnatal Day (P) 0 in Aqp1 À/þ and Aqp1 À/À mice (Fig. 2, A and B) . The weight of P0 embryos from Aqp1 À/À and Aqp1 À/þ mice also increased (Fig. 2B) . Thereafter, we counted the number of blood vessels, determined the placental mass, and quantified the labyrinthine layer area in placentae of the four genotypes. The number of blood vessels increased significantly with gestational age in placentae of Aqp1 À/þ and Aqp1 À/À mice (Fig. 2, C, E, and F) , and the labyrinthine layer area also increased (Fig. 2D) . These data indicate that Aqp1 maternal deficiency resulted in increases in the placental mass and the labyrinthine layer area.
Histological analysis revealed that placentae of Aqp1
and Aqp1 À/À mice showed disproportionate expansion of the junctional zone (JZ; Fig. 3A) . Moreover, morphometric analysis revealed that the ratios of the JZ to the whole placenta (JZ/placenta) and the labyrinthine layer to the whole placenta (lab/placenta) increased. Specifically, the JZ/placenta ratio in Aqp1 À/þ and Aqp1 À/À mice was 1.2-and 1.8-fold higher than that in Aqp1 þ/þ mice, respectively, while the lab/placenta ratio was nearly 1.2-fold higher (Fig. 3B) . To gain further insight into the expansion of the JZ in Aqp1
and Aqp1 À/À mice, Phlda2 mRNA expression was determined by qRT-PCR in placentae of the four genotypes. Phlda2 mRNA expression was repressed in placentae of Aqp1 À/þ and Aqp1 À/À mice (Fig. 3C ).
Aqp1 Expression in the Placenta and Embryo at E15.5
We analyzed the Aqp1 mRNA expression in placentae and embryos of the four genotypes at E15.5. As determined by qRT-PCR, placental Aqp1 mRNA expression decreased significantly in Aqp1 À/þ and Aqp1 À/À mice compared with Aqp1 þ/þ and Aqp1 þ/À mice (Fig. 4A) . Immunohistochemical analyses showed that the Aqp1 signal was present in the decidual and labyrinthine layers of placentae from Aqp1 þ/þ and Aqp1 þ/À mice, with weaker expression in the spongioblast layer. In Aqp1 À/þ and Aqp1 À/À mice, however, the Aqp1 signal was much weaker in the decidual and spongioblast layers (Fig. 4C) . Aqp1 mRNA expression was not detected in the brain, tongue, heart, lung, liver, and kidney in Aqp1 À/À embryos at E15.5, as determined by qRT-PCR. In addition, Aqp1 mRNA expression was reduced significantly in the brain, tongue, lung, liver, and kidney in Aqp1 À/þ and Aqp1 þ/À embryos. In wild-type Aqp1 þ/þ mice, Aqp1 was highly expressed in the lung and liver, with the lowest expression in brain and kidney, and moderate expression in the tongue and heart (Fig. 4B) .
Methylation Analysis of Aqp1 in Embryos at E15.5
Considering the differences in Aqp1 mRNA expression in the six organs at E15.5, we speculated that there might be differences in the methylation status in the Aqp1 promoter and exon 1, and that differences in methylation of the CpG sites in these regions might explain the mRNA expression pattern. To test this hypothesis, we scanned for possible CpG islands using CpG island searching software (http:// cpgislands.usc.edu/). We identified CpG islands based on the following criteria: regions of DNA greater than 200 bp with a GC content greater than 50%, and an observed/ expected CpG ratio greater than 60%. The promoter region was defined as 2000 bp upstream of the transcription start site (TSS). This analysis indicated that no CpG islands were located in the Aqp1 promoter; however, one CpG island was found in exon 1. The methylation status of 10 CpGs within 454 bp of the Aqp1 promoter region and 267 bp of exon 1 was also analyzed. Four representative tissues, namely, the brain, tongue, liver, and placenta, were chosen. The results show that region A (in the promoter) and region B (in exon 1) were almost completely methylated at 95% and 98.3% in the brain of embryos at E15.5, respectively (Fig. 5) , and that Aqp1 mRNA expression was barely detected (Fig. 4B) . In the tongue, the methylation state was 85% and 88.3% for region A and B, respectively. In the liver, these regions were hypomethylated at 16.7% and 31.7%, and Aqp1 was highly expressed (Figs. 4B and 5) . The methylation state of regions A and B in the placenta was only 8.3% and 7.2%, respectively (Fig. 5 ).
DISCUSSION
Currently, there are more than 150 imprinted genes in mammals [31] . Many imprinted genes, especially maternally expressed genes, associate closely with embryo and placental development. For example, maternally expressed Grb10 regulates the weights of the placenta and embryo. Phlda2, another maternally expressed gene, suppresses the development of the placental spongiotrophoblast layer and regulates the nutritional requirements of placentae. We found that Aqp1 is a novel, maternally expressed gene in the mouse placenta that plays an essential role in its development.
The placenta is crucial for mammalian development, contributing to the exchange of gas, nutrients, and waste between the mother and fetus [32] . The results from this study suggest that placental and embryonic weights increased in Aqp1 À/þ and Aqp1 À/À mice at E12.5-E18.5 in which Aqp1 expression are both significantly reduced, which lends further weight to the hypothesis proposed by Fowden et al. [14] . Compared with wild-type Aqp1 þ/þ mice, there was no change in placental and embryonic weights in Aqp1 þ/À mice. The weights of P0 embryos from Aqp1 À/À and Aqp1 À/þ mice also increased. The weight gain in P0 embryos from Aqp1 À/À and Aqp1 À/þ mice confirms the importance of cross-talk during placental and fetal growth, leading us to conclude that the GUO ET AL.
imprinted gene, Aqp1, indirectly influenced embryonic development by affecting placental development. A previous study reported that placenta-specific imprinted genes associate with vascularization of the labyrinthine zone and formation of the spongioblast layer [33] . Histological analysis showed that the number and branching of blood vessels also increased in the labyrinthine layer. In addition, H&E staining data demonstrated that the JZ/placenta and lab/placenta ratios increased at E15.5. These changes may result in the oversupply of nutrients and oxygen to the fetus, which is consistent with the conclusions of Fowden et al. [34] and Angiolin et al. [4] . These data suggest that a deficiency of maternally expressed Aqp1 in the placental spongioblast and labyrinthine layers greatly promotes the transfer of maternal nutrients to the embryo, and that Aqp1 may play an inhibitory role in placental development. These data also suggest that Aqp1 may prevent the maternal resources from being overtransferred to the placenta to avoid damage to the matrix by the overgrowth of the placenta and embryo during pregnancy in mice. Thus, Aqp1 maintains a nutrient balance between the fetus and the matrix.
As determined by RT-PCR, Phlda2 mRNA expression decreased significantly in placentae of Aqp1 À/þ and Aqp1
mice. The decrease in Phlda2 expression can result in placental overgrowth, a decrease of its spongiotrophoblast layer, and fetal growth restriction [8, 16] . We also speculated that Aqp1 suppresses the development of the spongiotrophoblast layer. Therefore, it is likely that Aqp1 and Phlda2 regulate the development of the spongiotrophoblast layer in an antagonistic manner. Phlda2 expression decreased to slow the overgrowth of the spongiotrophoblast layer in favor of its normal development in placentae of Aqp1 À/þ and Aqp1 À/À mice. However, the effects of Phlda2 on the development of the spongiotrophoblast layer were likely weaker than those of Aqp1, resulting in an increased spongiotrophoblast layer in Aqp1 knockout mice. In knockout mice of Phlda2, it was speculated that nutrients are excessively absorbed by the placenta instead of being effectively transferred to the embryo, contributing to a decrease in embryonic weight [16] . In Aqp1 À/À mice, by contrast, an increase in embryonic weight and an expansion of the spongiotrophoblast and labyrinthine layers were observed. To conclude, the placenta transfers nutrients to the embryo more efficiently when it can obtain sufficient maternal resources, resulting in an increase in embryonic weight.
The present study shows that Aqp1 expression was high in the liver and lung, moderate in the tongue and heart, and low in the kidney and brain. After knockout of paternal or maternal Aqp1, Aqp1 expression was reduced, and Aqp1 expression was almost undetectable in Aqp1 À/À embryos. Methylation is a well-studied epigenetic modification of mammalian genomic DNA, which occurs predominantly in 
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the region containing CpG dinucleotides (also known as CpG islands) [35] . In general, CpG methylation in a promoter can influence gene expression. Gene expression is suppressed by high methylation (hypermethylation), and promoted by low methylation (hypomethylation). Promoter hypermethylation that affects gene expression may indirectly favor the formation of heterochromatin by methyl-CpG binding proteins, or directly inhibit the transcriptional regulators binding to their cognate DNA region, where methylation within the gene body positively correlates with gene expression [35] [36] [37] . Brenet et al. demonstrated that methylation within exons, especially within the first exon, is highly correlated with gene expression and function [38] . For example, hypermethylation at individual CpG sites within exon 1 of H19 may be involved in the dysfunction of trophoblasts and the pathogenesis of preeclampsia [39] . The expression of the fatty acid synthase gene is significantly and negatively correlated with methylation of exon 1 [40] . In this study, CpG sites within the Aqp1 promoter and exon 1 were used to analyze the relationship between the methylation state and Aqp1 expression. Aqp1 expression is low in the brain, where methylation of CpG sites in the Aqp1 promoter and exon 1 was high, and high in the liver and placenta, where methylation was low. These data indicate that Aqp1 expression significantly and negatively correlates with the methylation state of the Aqp1 promoter and exon 1. Although the imprinting analysis of Aqp1 and its role in placental and embryonic development were studied using Aqp1 knockout mice, the Aqp1 regulatory mechanism is unclear, due to the unavailability of an appropriate SNP site used to distinguish the parents. Prospective studies should continue to address the role of imprinted genes in DNA methylation and histone modification.
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FIG. 3. Histological analysis of placental abnormalities in Aqp1
À/þ and Aqp1 À/À mice at E15.5. A) Histological analysis of placentae of the four genotypes by H&E staining. Black lines demarcate the labyrinthine (Lab; bottom), spongioblast (Spo; middle), and decidual (Dec; top) layers. The upper panels show low-magnification views (bar ¼ 500 lm) and the lower panels show high-magnification views (bar ¼ 200 lm). B) Spo/placenta and lab/ placenta ratios for the four genotypes (n ¼ 4). **P , 0.01 for the ratios of JZ/placenta and Lab/placenta of Aqp1 À/þ or Aqp1 À/À mice vs. Aqp1 þ/þ mice at E15.5. C) Phlda2 mRNA expression in placentae of the four genotypes at E15.5 by RT-PCR. The values are presented as the means 6 SD. ***P , 0.001 for Phlda2 mRNA expression in placentae of Aqp1 À/þ or Aqp1 À/À mice vs. Aqp1 þ/þ mice at E15.5.
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FIG. 4.
Aqp1 mRNA expression in placentae and embryos from E15.5 mice. A) Quantitative analysis of Aqp1 mRNA expression in placentae of the four genotypes at E15.5. The data were normalized to the b-actin level. The values are presented as the means 6 SD. ***P , 0.001 for Aqp1 mRNA expression in placentae from Aqp1 À/þ or Aqp1 À/À mice vs. Aqp1 þ/þ mice at E15.5. B) Aqp1 expression was analyzed in different embryonic tissues of the four genotypes at E15.5. The data were normalized to the b-actin level. C) Immunohistochemical analysis of Aqp1 expression in placentae of the four genotypes at E15.5 (bar ¼ 500 lm). Dec, decidual layer; Spo, spongioblast layer; Lab, labyrinth layer.
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